News Focus
News Focus
Post# of 257275
Next 10
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

Re: rkrw post# 89258

Wednesday, 01/20/2010 9:45:15 PM

Wednesday, January 20, 2010 9:45:15 PM

Post# of 257275
Re: MNTA

At a $600M+ market cap the downside risk of the fda pushing it back isn't trivial any more.

Ah, but is the upside potential of any M-Enoxaparin approval, let alone one of the sole generic variety, adequately priced in? ; )

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today